In conclusion, in this study, we report a design, molecular characterization and therapeutic investigation of a CCR8 antagonizing peptide AP8ii that inhibited monocyte-macrophage chemotaxis in vitro and ameliorated MoMFs infiltration, liver inflammation and early fibrosis in vivo. The gene discussed is CCR8; the disease is Hepatitis.